Spectranetics Corporation (SPNC) Finalizes EXCITE ISR Adjunct Analysis Plan
5/7/2013 9:53:27 AM
More...
|
Spectranetics Corporation (SPNC) Prices Public Offering of Common Stock
4/26/2013 11:05:00 AM
More...
|
Spectranetics Corporation (SPNC) Sets $85.5 Million as Target of Offering
4/26/2013 8:00:25 AM
More...
|
Spectranetics Corporation (SPNC) Seeking to Raise $250 Million
3/12/2013 8:25:47 AM
More...
|
Spectranetics Corporation (SPNC) Announces Expansion Into Japan Peripheral Intervention Market
1/29/2013 9:26:59 AM
More...
|
Spectranetics Corporation (SPNC) to Hold 2012 Fourth Quarter Financial Results Conference Call on February 21
1/28/2013 9:05:50 AM
More...
|
Final Results of Spectranetics Corporation (SPNC) Study Supports Successful Use of Laser Atherectomy for Treating Patients With Peripheral In-Stent Restenosis
1/24/2013 9:25:44 AM
More...
|
Spectranetics Corporation (SPNC) to Present at the 31st Annual J.P. Morgan Healthcare Conference
12/28/2012 9:02:06 AM
More...
|
Spectranetics Corporation (SPNC) to Participate in the 24th Annual Piper Jaffray Healthcare Conference
11/19/2012 11:03:11 AM
More...
|
Spectranetics Corporation (SPNC) Achieves Third Quarter Revenue of $35.2 Million
10/30/2012 6:53:03 AM
More...
|
|